Is a complete JSE/CCC research report available?

No complete published report is available for jse/CCC (JSE/CCC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

JSE/CCC (JSE/CCC)

Johannesburg Stock Exchange: JSE/CCC · ZAc

ZAC 100

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-02 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first JSE/CCC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	288.1M
Revenue (ttm)	7.1M
Net income (ttm)	-218.7M
EPS (ttm)	-ZAC 3.34
Shares out	288.1M
Volume	15,000
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.1M
Net income (ttm): -218.7M
EPS (ttm): -ZAC 3.34
Market cap: 288.1M

All JSE/CCC indicators

Market & fundamental data

Available fields

154

Groups with data

Currency

ZAR

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Africa
Country code	ZA
Enterprise value	ZAc 235.5M
Exchange	Johannesburg Stock Exchange
Financial currency	ZAR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	ZAE000310397
Last refreshed	2026-08-02
Market cap	ZAc 288.1M
Price	ZAc 100
Price currency	ZAc
Sector	Healthcare
Sector PE	19.25
Sector PE Fwd	15.18
Sic	2834
Symbol	jse/CCC
Website	https://www.cilocybin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-75.9%
EV/Sales	33.02x
FCF yield	-0.4%
P/B ratio	2.88x
P/S ratio	40.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	5.13%
Gross Profit	ZAc 365,983
Gross Profit Growth	-97.86%
Gross Profit Growth Q	-27.77%
Net Income	ZAc -218.7M
Net Income Growth Years	0%
Pretax Margin	-3,081.98%
ROA	-164.5
ROCE	-214.4
ROE	-273.2
ROIC	-168.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-66.13%
EPS Growth Years	0
FCF Growth Q	108.42%
OCF Growth	-73.52%
OCF Growth Q	145.29%
Revenue Growth	-58.8x
Revenue Growth Q	14.18x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ZAc 0.08
Assets	ZAc 108.9M
Cash	ZAc 58.3M
Current Assets	ZAc 90.1M
Current Liabilities	ZAc 4.9M
Debt	ZAc 5.6M
Debt Equity	ZAc 0.06
Debt FCF	ZAc -4.89
Equity	ZAc 100.2M
Liabilities	ZAc 8.8M
Long Term Assets	ZAc 18.9M
Long Term Liabilities	ZAc 3.9M
Net Cash	ZAc 52.6M
Net Cash By Market Cap	ZAc 18.27
Net Cash Growth	-12.58%
Net Debt Equity	ZAc -0.53
Tangible Book Value	ZAc 100.2M
Tangible Book Value Per Share	ZAc 0.35
WACC	8.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.49
Net Working Capital	ZAc 28.7M
Quick ratio	14.84
Working Capital	ZAc 85.2M
Working Capital Turnover	ZAc 0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	19.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-66.1%
200-day SMA	181.6
50-day SMA	89.26
50-day SMA vs 200-day SMA	50under200
All Time High	1,000
All Time High Change	-90%
All Time High Date	2024-07-01
All Time Low	70
All Time Low Change	42.86%
All Time Low Date	2026-03-23
ATR	1.86
Beta	0.58
Beta1y	0.83
Beta2y	0.42
Ch YTD	-53.49
High	100
High52	690
High52 Date	2025-10-06
High52ch	-85.51%
Low	100
Low52	70
Low52 Date	2026-04-13
Low52ch	42.86%
Ma50ch	12.03%
Price vs 200-day SMA	-44.95%
RSI	74.51
RSI Monthly	35.18
RSI Weekly	40.52
Sharpe ratio	0.14x
Sortino ratio	0.25
Total Return	19.08%
Tr YTD	-53.49
Tr1m	28.21%
Tr3m	23.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ZAc -223.1M
Operating margin	-3,128.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	169,399,737%
Net Borrowing	-3,151,416
Shares Insiders	11.22%
Shares Out	288,088,772
Shares Qo Q	30.89%
Shares Yo Y	-19.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,251.9x
Bv Per Share	0.35
CAPEX	ZAc -1.8M
Ch1m	28.21
Ch1y	-66.1
Ch3m	23.46
Ch6m	-50
Change	0%
Change From Open	0
Close	100
Days Gap	0
Depreciation Amortization	247,153
Dollar Volume	1,500,000
Earnings Date	2026-06-26
EBIT	ZAc -223.1M
EBITDA	ZAc -222.9M
EPS	ZAc -3.34
F Score	2
FCF	ZAc -1.2M
FCF EV Yield	-0.49x
FCF Per Share	ZAc -0
Financing CF	-5,357,516
Fiscal Year End	March
Founded	2,018
Income Tax	ZAc -1.1M
Investing CF	-1,828,333
Is Primary Listing	1
Last Earnings Date	2026-02-20
Last Report Date	2025-09-30
Ma150	129.6
Ma150ch	-22.82%
Ma20	84.6
Ma20ch	18.2%
Net CF	-6,508,426
Open	100
P OCF Ratio	424.7
Ppne	14,355,375
Price Date	2026-07-31
Ptbv Ratio	2.88
Relative Volume	11.98x
Revenue	7,131,743x
Tax By Revenue	-16.04x
Tr6m	-50%
Volume	15,000
Z Score	8.1

JSE/CCC (JSE/CCC)

Coverage state: Market snapshot only — no published research

Generate the first JSE/CCC analysis

Price

Financial snapshot

Fair-value bridge

Latest news · JSE/CCC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All JSE/CCC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on JSE/CCC

Frequently asked questions